Change in Functional Beta Cell Capacity With Time Following Autologous Islet Transplantation.


Journal

Pancreas
ISSN: 1536-4828
Titre abrégé: Pancreas
Pays: United States
ID NLM: 8608542

Informations de publication

Date de publication:
Historique:
entrez: 16 5 2019
pubmed: 16 5 2019
medline: 23 2 2020
Statut: ppublish

Résumé

Autologous islet transplantation (AIT) is performed to preserve insulin secretory function in chronic pancreatitis patients undergoing total pancreatectomy (TP). No data exist on the effect of time lapse on beta cell function post TP-AIT. We aimed to investigate the factor of time lapse on beta cell function following TP-AIT. Retrospectively, we identified 31 adult patients with chronic pancreatitis who underwent TP-AIT between 2008 and 2016. Changes in beta cell function were assessed using (1) BETA-2 scores and (2) analysis of posttransplant mixed-meal tolerance testing. Significant decrease in functional beta cell capacity expressed by BETA-2 scores was seen in the first 2 years following TP-AIT, with an annual decrease of 6.3 points in median BETA-2 score (interquartile range, 4.6-11.6; P = 0.002). In the mixed-meal tolerance testing analysis, nonsignificant trends toward higher glucose, lower insulin, and lower C-peptide were seen with time lapse. Additionally, higher hemoglobin A1c values (P = 0.033) and higher insulin requirements (P = 0.04) were seen with longer follow-up after AIT. A steady drop in functional beta cell capacity was observed in the 2 years following TP and AIT. To our knowledge, to date this is the first report of the BETA-2 score applicability in the AIT setting.

Identifiants

pubmed: 31091212
doi: 10.1097/MPA.0000000000001315
pii: 00006676-201905000-00011
doi:

Substances chimiques

Blood Glucose 0
C-Peptide 0
Glycated Hemoglobin A 0
Hypoglycemic Agents 0
Insulin 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

656-661

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Auteurs

Khawla F Ali (KF)

From the Endocrinology and Metabolism Institute and.

Vicente T San Martin (VT)

From the Endocrinology and Metabolism Institute and.

R Matthew Walsh (RM)

Digestive Disease Institute, Cleveland Clinic, Cleveland, OH.

Tyler Stevens (T)

Digestive Disease Institute, Cleveland Clinic, Cleveland, OH.

Betul Hatipoglu (B)

From the Endocrinology and Metabolism Institute and.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH